Evidence map›Paper›PMID 33875437›Full record

ArticleAntimicrobial agents and chemotherapy2021

Role of the SOS Response in the Generation of Antibiotic Resistance

John K Crane, Cassandra L Alvarado, Mark D Sutton

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

John K CraneDepartment of Medicine, Division of Infectious Diseases, University at Buffalo, Buffalo, New York, USA.
Cassandra L AlvaradoDepartment of Medicine, Division of Infectious Diseases, University at Buffalo, Buffalo, New York, USA.
Mark D SuttonDepartment of Biochemistry, University at Buffalo, Buffalo, New York, USA.
University at Buffalo, State University of New York · US

Funding

The SOS Response as a Generator of Antibiotic Resistance and Role of Zinc as SOS InhibitorR21AI145836 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI CRANE, JOHN K. · 2019 to 2020
$435k
HHS | National Institutes of Health (NIH) R21 AI 145836NIAID NIH HHS R21 AI145836
6 · The paper itself

Abstract

The SOS response to DNA damage is a conserved stress response in Gram-negative and Gram-positive bacteria. Although this pathway has been studied for years, its relevance is still not familiar to many working in the fields of clinical antibiotic resistance and stewardship. Under some conditions, the SOS response favors DNA repair and preserves the genetic integrity of the organism. On the other hand, the SOS response also includes induction of error-prone DNA polymerases, which can increase the rate of mutation, called the mutator phenotype or "hypermutation." As a result, mutations can occur in genes conferring antibiotic resistance, increasing the acquisition of resistance to antibiotics. Almost all of the work on the SOS response has been on bacteria exposed to stressors

Indexed as

Escherichia coliSOS Response, GeneticsAnimalsAnti-Bacterial AgentsCiprofloxacinDrug Resistance, MicrobialMutationRabbitsAnti-Bacterial AgentsCiprofloxacinenteropathogenic E. colifosfomycinheteroresistancehypermutationminocyclinerabbit modelRecArifampinzidovudinezinc

Identifiers

PMID33875437
PMCPMC8373240
OpenAlexW3155857195

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.